Results 201 to 210 of about 10,512 (256)

Draft genome sequences of <i>Bacillus</i> and <i>Pseudomonas</i> species isolated from <i>Cannabis sativa</i> L. and <i>Chelidonium majus</i> L. [PDF]

Microbiol Resour Announc
Amaya-Quiroz L, Kaddoura MJ, Rani M, Samsatly J, Meglouli H, Sater MRA, George S.   +6 more
europepmc   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

Journal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Sabine Elisabeth Groeger, Yuxi Zhou, Jiawen Yong, Lei Wang, Sabine Ruf, Joerg Meyle   +5 more
wiley   +1 more source

Evolving health policy and regulatory oversight of medicinal cannabis in Australia: lessons for sustainable integration. [PDF]

J Cannabis Res
Lim ECN, Lim CED.
europepmc   +1 more source

Impaired Alertness Correlates With Chronic Anxiety: A Prospective Tertiary University Centre Cohort

Journal of Sleep Research, EarlyView.
ABSTRACT The Maintenance of Wakefulness Test (MWT) is a widely used objective measure of daytime alertness, especially in patients with sleep disorders at increased risk of accidents. Anxiety and depression are common in this population and may influence subjective sleepiness and objective alertness.
Anice Borjon, Lucie Bobin, François Ricordeau, Lucas Marces, Hugo Fornelli, Thierry Petitjean, Amandine Viccica, Elena Charbonnier, Emeric Stauffer, Barbara Charbotel, Jacques Taillard, Renaud Tamisier, Laure Peter‐Derex, Pierre Tankéré   +13 more
wiley   +1 more source

Gimmie the Gummies: Initial validation of the Edibles Marijuana Purchase Task. [PDF]

Exp Clin Psychopharmacol
Aston ER, Amlung M.
europepmc   +1 more source

Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof‐Of‐Concept Study of Alixorexton

Journal of Sleep Research, EarlyView.
Orexin 2 receptor agonists have demonstrated that targeting the orexin system may address symptoms of central disorders of hypersomnolence. Results of this phase 1 study support the phase 2 clinical evaluation of oral alixorexton in patients with IH, NT2 and NT1.
Ronald R. Grunstein, Brendon J. Yee, Julia L. Chapman, Jian Eu Tai, Sheila Sivam, Craig Hopkinson, Daniel G. Smith, Alexandra Lovett, Shifang Liu, Sergey Yagoda, Bhaskar Rege   +10 more
wiley   +1 more source

Patent landscape analysis of inventions based on plant genetic resources for food and agriculture and related digital sequence information

The Journal of World Intellectual Property, EarlyView.
Abstract This article provides an overview of the patent landscape in relation to PGRFA‐based inventions involving naturally occurring (“native”) traits and related Digital Sequence Information/Genetic Sequence Data (DSI/GSD). In particular, it focuses on the potential of patent claims to limit others' uses of PGRFA and related DSI/GSD on which the ...
Claudio Chiarolla, Michael Andreas Kock, Paul Oldham, Michael Halewood, Isabel López Noriega, Jasmine Kindness   +5 more
wiley   +1 more source

Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in Australia. [PDF]

J Cannabis Res
Lintzeris N, Arnold JC, McGregor IS, Mills L.   +3 more
europepmc   +1 more source

Clinical Health Messaging for Perinatal Cannabis Use: Perspectives From Postpartum Individuals With Use During Early Pregnancy. [PDF]

Subst Use Addctn J
Ogden SN, Foti TR, Does MB, Altschuler A, Iturralde E, Ansley D, Castellanos C, Young-Wolff KC.   +7 more
europepmc   +1 more source

Interplay between the HPA axis and inflammation as mechanisms therapeutic targets of <i>Cannabis sativa</i> in depression. [PDF]

Front Pharmacol
Pilatti F, Philippsen M, Bertollo AG, Webler CP, Bordignon AK, Ignácio ZM.   +5 more
europepmc   +1 more source